Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

ETHSX vs. DLHIX: which is better?

Bottom line

ETHSX vs DLHIX: the short answer

ETHSX (Eaton Vance Worldwide Health Sciences Fund) and DLHIX (Nomura Healthcare Fund) share a meaningful slice of their top holdings — about 42% by weight.

But DLHIX is far broader, holding 108 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.

DLHIX is cheaper at 0.96% vs 1.18% — a difference of $22 a year per $10,000 invested.

Over five years, DLHIX returned +7.8% a year vs +5.3% for ETHSX (reporting dates differ).

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

ETHSX vs DLHIX side by side

ETHSXDLHIX
TypeMutual fundMutual fund
Fund familyMorgan StanleyVoya
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.18%0.96%
Annual cost per $10k$118$96
10-yr cost on $10k (prospectus)$1,911$1,232
Max front load5.25%0%
12b-1 fee0.25%0%
1-yr return−1.9%+22.4%
5-yr return (annualized)+5.3%+7.8%
10-yr return (annualized)+6.4%+10.4%
Best quarter+14.2%—
Worst quarter−12.1%—
Net assets (fund)$757.9M$750.2M
Number of holdings42108
Portfolio turnover3%4%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

10 of ETHSX's top 25 holdings also appear in DLHIX's top 25.

Shared top holdings
HoldingETHSXDLHIX
Eli Lilly & Co12.47%4.16%
AbbVie Inc6.46%4.19%
AstraZeneca PLC6.24%3.27%
UnitedHealth Group Inc5.49%3.88%
Roche Holding AG5.44%3.01%
Merck & Co Inc5.08%3.68%
Vertex Pharmaceuticals Inc3.38%1.66%
Gilead Sciences Inc3.34%3.54%
Boston Scientific Corp2.18%1.42%
Neurocrine Biosciences Inc1.41%1.57%

Source: SEC Form N-PORT

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

DLHIX top 10

  1. Ucb Sa — 5.19%
  2. Abbvie Inc — 4.19%
  3. Eli Lilly & Company — 4.16%
  4. Regeneron Pharmaceuticals Inc — 3.91%
  5. Unitedhealth Group Inc — 3.88%
  6. Pfizer Inc — 3.84%
  7. Merck & Company Inc — 3.68%
  8. Gilead Sciences Inc — 3.54%
  9. Astrazeneca Plc — 3.27%
  10. Elevance Health Inc — 3.25%

FAQ

What is the difference between ETHSX and DLHIX?
ETHSX (Eaton Vance Worldwide Health Sciences Fund) and DLHIX (Nomura Healthcare Fund) share a meaningful slice of their top holdings — about 42% by weight. But DLHIX is far broader, holding 108 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.
Which is cheaper, ETHSX or DLHIX?
DLHIX has the lower expense ratio (0.96%).
Should I own both ETHSX and DLHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.